SCHEMBL5999925

SCHEMBL5999925

CC(C)CCN(CC(=O)O)Cc1nc(-c2ccc(NCCc3ccc(C4CCCCC4)cc3)cc2)cs1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
POLB P06746 1/20 0.38
MRE11 P49959 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.36
MMP2 P08253 1/20 0.35
MMP3 P08254 1/20 0.35
UBE2M P61081 1/20 0.34
DCUN1D1 Q96GG9 1/20 0.34
ALOX5 P09917 1/20 0.34
TRPA1 O75762 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
ADRB3 P13945 3/20 0.34
MAPT P10636 2/20 0.34
GAA P10253 1/20 0.34
ALDH1A1 P00352 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6000726 0.88 RAB9A (0.42) PTPN2PTPN1NPC1RAB9AMEN1
SCHEMBL6000607 0.87 MEN1 (0.44) PTPN2PTPN1NPC1RAB9AMEN1
SCHEMBL5999224 0.87 NPC1 (0.41) PTPN2PTPN1NPC1RAB9AMEN1
SCHEMBL6000824 0.86 RORC (0.37) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL5999919 0.85 PTPN2 (0.40) PTPN2PTPN1MRE11ALOX5TRPA1
SCHEMBL6000148 0.85 NPC1 (0.41) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL5999152 0.84 MEN1 (0.43) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL5999761 0.81 MEN1 (0.43) PTPN2PTPN1NPC1RAB9AMEN1
SCHEMBL6000700 0.81 NPC1 (0.39) NPC1RAB9AMEN1KMT2APOLB
SCHEMBL6000797 0.81 MEN1 (0.43) PTPN2PTPN1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PTPN2 11/4885PTPN1 2/4885NPC1 955/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.